Hypothesis: Compartmentalization of cytokines in intraabdominal infection

Surgery

Volumn 119, Issue 6, 1996, Pages 694-700

  Schein, M ^a   Wittmann, D H ^a   Holzheimer, R ^a   Condon, R E ^a  

^a NEW YORK METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; BACTERIAL PERITONITIS; HEMOFILTRATION; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SEPSIS;

EID: 0030000877     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(96)80195-4     Document Type: Article

References (80)

1. Wittmann H, Walker A, Condon R. Peritonitis and intraabdominal infection. 6th ed. In: Schwartz SI, Shires GT, Spencer FC, editors. Principles of surgery. New York: McGraw-Hill, Inc.
2. Maddaus MA Ahrenholz D Simmons RL The biology of peritonitis and implications for treatment Surg Clin North Am 68 1988 431 443
3. Shapiro L Gelfand JA Cytokines and sepsis: pathophysiology and therapy New Horizons 1 1993 13 22
4. Beutler B Endotoxin, tumor necrosis factor, and related mediators: new approaches to shock New Horizons 1 1993 3 12
5. Parrilo JE Pathogenetic mechanisms of septic shock N Engl J Med 328 1993 1471 1476
6. Fong Y Moldawer LL Shires GT Lowry SF The biologic characteristics of cytokines and their implication in surgical injury Surg Gynecol Obstet 170 1990 363 378
7. Giroir BP Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade Crit Care Med 21 1993 780 789
8. Lynn WA Cohen J Adjunctive therapy for septic shock: a review of experimental approaches Clin Infect Dis 20 1995 143 158
9. Christman JW Holden EP Blackwell TS Strategies for blocking the systemic effects of cytokines in the sepsis syndrome Crit Care Med 23 1995 955 963
10. Takesue Y Experimental study on the development of endotoxemia in peritonitis with special reference, to route of absorption of endotoxin J Jap Surg Soc 88 1987 327 339
11. Fujimoto M Experimental study on the effect of various types of peritonitis and elevation of intra-abdominal pressure on endotoxin absorption J Jap Surg Soc 90 1989 1989 1999
12. Olofsson P Evaluation of the effects of lymph drainage by a thoracic duct fistula in experimental peritonitis Acta Chir Scand 154 1988 453 459
13. Ayala A Kisala JM Felt JA Perrin MM Chaudry IH Does endotoxin tolerance prevent the release of inflammatory monokines (Interleukin 1, Interleukin 6 or Tumor Necrosis Factor) during sepsis? Arch Surg 127 1992 191 197
14. Ertel W Morrison MH Wang P Ba ZF Ayala A Chaudry IH The complex pattern of cytokines in sepsis Ann Surg 214 1991 141 148
15. Mayoral JL Schweich CJ Dunn DL Decreased tumor necrosis factor production during the initial stages of infection correlates with survival during murine gram-negative sepsis Arch Surg 125 1990 24 28
16. Rasmussen LT Fandrem J Seljelid R Dynamics of blood components and peritoneal fluid during treatment of murine E. coli sepsis with beta-1,3-D-polyglucose derivatives. Interleukin I, tumor necrosis factor, prostaglandin E2 and leukotriene B4 Scand J Immunol 32 1990 333 340
17. Bagby GJ Plessala KJ Wilson LA Thompson JJ Nelson S Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis J Infect Dis 163 1991 83 88
18. McMasters KM Cheadle WG Regulation of macrophage TNF alpha, IL-1 beta, and Ia (I-A alpha) mRNA expression during peritonitis is site dependent J Surg Res 54 1993 426 430
19. Astiz ME Saha DC Carpati CM Rackow EC Induction of endotoxin tolerance with monophosphoryl lipid A in peritonitis: importance of localized therapy J Lab Clin Med 123 1994 89 93
20. Zanetti G Heumann D Gerain J Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide J Immunol 148 1992 1890 1897
21. Hohler J Heumann D Garotta G IFN-gamma involvement in the severity of gram-negative infections in mice J Immunol 151 1993 916 921
22. Natanson C Hoffman WD Suffredini AF Eichacker PQ Danner RL NIH conference. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis Ann Intern Med 120 1994 771 783
23. van Furth R van Zwet ThL Buisman AM van Dissel JT Anti-tumor necrosis antibodies inhibit the influx of granulocytes and monocytes into an inflammatory exudate and enhance the growth of Listeria monocytogenes in various organs J Infect Dis 170 1994 234 237
24. Echtenacher B Falk W Mannel DN Krammer PH Requirement of endogenous tumor necrosis factor/cachectin for recovery from experimental peritonitis J Immunol 145 1990 3762 3766
25. Stack AM Saladino RA Thompson C Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit Crit Care Med 23 1995 512 518
26. Lange JR Alexander HR Merino MJ Doherty GM Norton JA Interleukin-1 alpha prevention of the lethality of Escherichia coli peritonitis J Surg Res 52 1992 555 559
27. Callery MP Kamei T Flye W Kupffer cell blockade increases mortality during intra-abdominal sepsis despite improving systemic immunity Arch Surg 125 1990 36 41
28. Maddaus MA Simmons RL Intraperitoneal administration of recombinant interleukin-2 protects against lethal IP Gram-negative sepsis by induction of a neutrophil influx Surgery Forum Chicago, American College of Surgeons 1988 105 106
29. Chong KT Prophylactic administration of interleukin-2 protects mice from lethal challenge with Gram-negative bacteria Infect Immun 55 1987 668 673
30. van der Poll T Marchant A Berman L Endogenous interleukin-10 protects against death in septic peritonitis in mice Surgery Forum Chicago, American College of Surgeons 1994 18 20
31. Napolitano LM Campbell C Interleukin-10 (IL-10) decreases mortality in a lethal murine trauma/sepsis model Abstract. Proceedings of the Fifteenth Annual Meeting of the Surgical Infection Society Louisville April 20–22, 1995
32. Chalkiadakis GE Kostakis A Karayannacos PE Pentoxifylline in the treatment of experimental peritonitis in rats Arch Surg 120 1985 1141 1144
33. Thompson JN Whawell SA Pathogenesis and prevention of adhesion formation Br J Surg 82 1995 3 5
34. Whawell SA Scott-Commbes D Vipond MN Tebbutt SJ Thompson JN Tumour necrosis factor-mediated release of plasminogen activator inhibitor 1 by human peritoneal mesothelia cells Br J Surg 81 1994 214 216
35. Holzheimer RG Molloy RG O'Riordain DS Long-term immunotherapeutic intervention with pentoxifylline in a mouse model of thermal injury and infection J Trauma 38 1995 757 762
36. Alexander HR Doherty GM Venzon DJ Merino MJ Fraker DL Norton JA Recombinant interleukin-1 receptor antagonist (IL-1ra): effective therapy against gram-negative sepsis in rats Surgery 112 1992 188 194
37. Starnes HF Pearce MK Tewari A Yim JH Zou JC Abrams JS Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-alpha challenge in mice J Immunol 145 1990 4185 4191
38. O'Reilly M Silver GM Greenhalgh DG Gamelli RL Davis JH Hebert JC Treatment of intra-abdominal infection with granulocyte colony-stimulating factor J Trauma 33 1992 679 682
39. Molloy RG Holzheimer R Nestor M Collins K Mannick JA Rodrick ML Granulocyte-macrophage colony-stimulating factor modulates function and improves survival after experimental thermal injury Br J Surg 82 1995 770 776
40. Lorenz W Reimund KP Weitzel F Granulocyte colonystimulating factor prophylaxis before operation protects against lethal consequences of postoperative peritonitis Surgery 116 1994 925 934
41. Betjes MG Tuk CW Struijk DG Krediert R^ Arisz L Hart M Beelen RH Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-alpha, and interleukin conditioned by macrophages cocultured with Staphylococcus epidermidis J Infect Dis 168 1993 1202 1210
42. Topley N Jorres A Luttmann E Human peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF alpha Kidney Int 43 1993 226 233
43. Fieren MW van den Bemd GJ Bonta IL Ben-Efraim S Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to releasc tumour necrosis factor during pereritonitis J Clin Lab Immunol 31 1991 1 9
44. Hart PH Jones CA Finlay-Jones JJ Inflammatory fluids regulate TNF-alpha, but not II-1 beta, production by human peritoneal macrophages. A study of patients on continuous ambulatory peritoneal dialysis with peritonitis J Leuk Biol 53 1993 309 319
45. Nakahama H Tanaka Y Shirai D Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients Nephron 61 1992 132 134
46. Zemel D Krediet RT Koomen GC Kortekaas WM Hertzen HG ten Berge RG Interleukin-8 during peritonitis in patients treated with CAPD: an in-vivo model of acute inflammation Nephrol Dial Transplant 9 1994 169 174
47. Zemel D Koomen GC Hart AA ten Berge IJ Struijk DG Krediet RT Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis J Lab Clin Med 122 1993 686 696
48. Propst T Propst A Herold M Spontaneous bacterial peritonitis is associated with high levels of interleukin-6 and its secondary mediators in ascitic fluid Eur J Clin Invest 23 1993 832 836
49. Zeni F Tardy B Vindimian M High levels of tumor necrosis factor-alpha and interleukin-6 in the ascitic fluid of cirrhotic patients with spontaneous bacterial peritonitis Clin Infect Dis 17 1993 218 223
50. Dames P Leduc D Ns M Cytokine serum level during severe sepsis in human. IL-6 as a marker of severity Ann Surg 215 1992 356 362
51. Fugger R Zadrobilek E Gotzinger P Perioperative TNF alpha and IL-6 concentrations correlate with septic sate, organ dysfunction, and APACHE II scores in intra-abdominal infection Eur J Surg 159 1993 525 529
52. Patel RT Deen KI Youngs D Warwick J Keighley MRB Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis Br J Surg 81 1994 1306 1308
53. Hamilton G Hofbauer S Hamilton B Endotoxin, TNF-alpha, interleukin-6, and parameters of cellular immune system in patients with intraabdominal sepsis Scand J Infect Dis 24 1992 361 368
54. Holzheimer RE Schein M Wittmann DH Inflammatory response in peritoneal exudate and plasma of patients undergoing planned relaparotomy for severe secondary peritonitis Arch Surg 130 1995 1314 1320
55. Livingston DH Mosenthal AC Deitch EA Sepsis and multiple organ dysfunction syndrome: a clinical-mechanistic overview New Horizons 3 1995 257 266
56. Strohmaier W Redl H Schlag G Inthoran D D-erythro-neopterin plasma levels in, intensive care patients with and without septic complications Crit Care Med 15 1987 757 760
57. Duswald KH Jochum M Schramm E Fritz H Released granulocyte elastase: an indicator of pathobiochemical alterations in septicemia after abdominal surgery Surgery 98 1985 892 898
58. Deitch EA Cytokines yes, cytokines no, cytokines maybe? Crit Care Med 21 1993 817 819
59. Meyer TA Wang Jingjing W Tiao GM Ogle CK Fischer JE Hasselgren PO Sepsis and entotoxemia stimulate intestinal interleukin-6 production Surgery 118 1995 336 342
60. Baigrie RJ Lamont PM Kwiatkowski D Dallman MJ Morris PJ Systemic cytokine response after major surgery Br J Surg 79 1992 757 760
61. Ueo H Inoue H Honda M Production of interleukin-6 at operative wound sites in surgical patients J Am Coll Surg 179 1994 326 332
62. Glaser F Sannwald GA Buhr H General stress response to conventional and laparoscopic cholecystectomy Ann Surg 221 1995 372 380
63. Grewal HP Kotb M El Din D Induction of tumor necrosis factor in severe acute, pancreatitis and its subsequent reduction after hepatic passage Surgery 115 1994 213 221
64. Riché F Dosquet C Panis Y Levels of portal and systemic blood cytokines after colectomy in patients with carcinoma or Crohn's disease J Am Coll Surg 180 1995 718 724
65. Aprahamian C Schein M Wittmann D Cefotaxime and metronidazole in severe intra-abdominal infection Diagn Microbiol Infect Dis 22 1995 183 188
66. Rotstein OD Meakins JL Diagnostic and therapeutic challenges of intraabdominal infections World J Surg 14 1990 159 166
67. Lustar I Gontmacher A Närska V Five days of antibacterial therapy for bacterial meningitis in children Infection 23 1995 113 118
68. Yoon BH Romero R Kim CJ Amniotic fluid interleukin-6: a sensitive test for anternatal diagnosis of acute inflammatory lesions of the preterm placenta and prediction of perinatal morbidity Am J Obstet Gynecol 172 1995 960 970
69. Schein M Assalia A Bachus H Minimal antibiotic therapy after emergency abdominal surgery: a prospective study Br J Surg 81 1994 989 991
70. [abstract] Waydhas C Nast-Kolb D Kick M Posttraumatic inflammatory response, secondary operations, and late multiple organ failure J Trauma 74 1994 164
71. Deitch EA Tumor necrosis factor as the proximal mediator of sepsis-Or this too will pass Crit Care Med 23 1995 1457 1458
72. Bone RC Sepsis, SIRS and MODS: the new definition Proceedings of Sepsis/SIRS Washington DC February 21–22, 1995
73. Barriere SL Lowry SF An overview of mortality risk prediction in sepsis Crit Care Med 23 1995 376 393
74. Schetz M Ferdinande P Van den Berghe G Verwaest C Lauwers P Removal of pro-inflammatory renal replacement therapy: sense or nonsense? Intensive Care Med 21 1995 169 176
75. Ahmed NA Christou NV Meakins JL The systemic inflammatory response syndrome and the critically ill surgical patient Curr Opin Crit Care 1 1995 290 305
76. Lee PA Matson JR Pryor RW Hinshaw LB Continuous arteriovenous hemofiltration therapy for staphylococcus aureus-induced septicemia in immature swine Crit Care Med 21 1993 914 924
77. Freeman BD Yatsiv I Natanson C Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock J Am Coll Surg 180 1995 286 292
78. Prins JM Deventer SJH Kruijper EJ Speelman P Clinical relevance of antibiotic-induced endotoxin release Antimicrob Agent Chemoth 38 1994 1211 1218
79. Shenep IL Mogan KA Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis J Infect Dis 150 1984 380 388
80. McRea JC Callahan J Don't block local cytokines: remove excess cytokines from the systemic circulation Abstract Proceedings of Sepsis/SIRS Washington, DC February 21–22, 1995